标题
Multiple sclerosis
作者
关键词
-
出版物
Nature Reviews Disease Primers
Volume 4, Issue 1, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-11-08
DOI
10.1038/s41572-018-0041-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis
- (2018) Sabina Luchetti et al. ACTA NEUROPATHOLOGICA
- Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
- (2018) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies
- (2018) Pietro Maggi et al. ANNALS OF NEUROLOGY
- T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention
- (2018) Jamie van Langelaar et al. BRAIN
- The value of oligoclonal bands in the multiple sclerosis diagnostic criteria
- (2018) Georgina Arrambide et al. BRAIN
- The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells
- (2018) Joana Machado-Santos et al. BRAIN
- Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome
- (2018) Clara Matute-Blanch et al. BRAIN
- The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review
- (2018) Leah J. Mische et al. Current Treatment Options in Neurology
- Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?
- (2018) Jeffrey Lambe et al. Current Treatment Options in Neurology
- MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
- (2018) S. Jarius et al. Journal of Neuroinflammation
- Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis
- (2018) Hanane Touil et al. Journal of Neuroinflammation
- Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis
- (2018) Jana Pöttgen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
- (2018) Raju Kapoor et al. LANCET NEUROLOGY
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
- (2018) Alan J Thompson et al. LANCET NEUROLOGY
- Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study
- (2018) Massimo Filippi et al. LANCET NEUROLOGY
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations
- (2018) Nicola De Stefano et al. Multiple Sclerosis Journal
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Reassessing B cell contributions in multiple sclerosis
- (2018) Rui Li et al. NATURE IMMUNOLOGY
- The current role of MRI in differentiating multiple sclerosis from its imaging mimics
- (2018) Ruth Geraldes et al. Nature Reviews Neurology
- Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis
- (2018) Alexander Rae-Grant et al. NEUROLOGY
- Multiple Sclerosis: Mechanisms and Immunotherapy
- (2018) Clare Baecher-Allan et al. NEURON
- IL-1β enables CNS access to CCR2himonocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells
- (2018) Alexandre Paré et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- People with multiple sclerosis report significantly worse symptoms and health related quality of life than the US general population as measured by PROMIS and NeuroQoL outcome measures
- (2018) Dagmar Amtmann et al. Disability and Health Journal
- A Review of the Current Evidence on Gadolinium Deposition in the Brain
- (2018) Richard Pullicino et al. Clinical Neuroradiology
- Effector T Cells in Multiple Sclerosis
- (2018) Belinda J. Kaskow et al. Cold Spring Harbor Perspectives in Medicine
- Regulatory T Cells: From Discovery to Autoimmunity
- (2018) Alexandra Kitz et al. Cold Spring Harbor Perspectives in Medicine
- Multiple Sclerosis Pathology
- (2018) Hans Lassmann Cold Spring Harbor Perspectives in Medicine
- Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome
- (2018) Hanna G. Zimmermann et al. JAMA Neurology
- Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis
- (2018) Mathias Granqvist et al. JAMA Neurology
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations
- (2018) Nicola De Stefano et al. Multiple Sclerosis Journal
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
- (2018) Xavier Montalban et al. Multiple Sclerosis Journal
- Worldwide prevalence of familial multiple sclerosis: A systematic review and meta-analysis
- (2018) Mohammad Hossein Harirchian et al. Multiple Sclerosis and Related Disorders
- Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis
- (2018) Peter J. Darlington et al. Frontiers in Immunology
- Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
- (2018) Ivan Jelcic et al. CELL
- MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder
- (2018) Ram Narayan et al. Multiple Sclerosis and Related Disorders
- Multiple sclerosis: Frequency, cost, and economic burden in the United States
- (2017) Alex Y. Chen et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses
- (2017) Rui Li et al. JOURNAL OF IMMUNOLOGY
- B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
- (2017) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study
- (2017) Nils Koch-Henriksen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study
- (2017) Hanne Marie Bøe Lunde et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cortical Remyelination Is Heterogeneous in Multiple Sclerosis
- (2017) Eva M.M. Strijbis et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- NEDA treatment target? No evident disease activity as an actionable outcome in practice
- (2017) Natalie E. Parks et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Evolving concepts in the treatment of relapsing multiple sclerosis
- (2017) Giancarlo Comi et al. LANCET
- Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
- (2017) Ari J Green et al. LANCET
- Diagnosis of multiple sclerosis: progress and challenges
- (2017) Wallace J Brownlee et al. LANCET
- Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
- (2017) Axel Petzold et al. LANCET NEUROLOGY
- Exercise in patients with multiple sclerosis
- (2017) Robert W Motl et al. LANCET NEUROLOGY
- Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor
- (2017) Georgina Arrambide et al. Multiple Sclerosis Journal
- Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm
- (2017) Andrew J Solomon et al. Multiple Sclerosis Journal
- Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
- (2017) Maria Pia Amato et al. Multiple Sclerosis Journal
- Targets of therapy in progressive MS
- (2017) Hans Lassmann Multiple Sclerosis Journal
- New insights into the burden and costs of multiple sclerosis in Europe
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Comorbidity in multiple sclerosis: implications for patient care
- (2017) Ruth Ann Marrie Nature Reviews Neurology
- Treatment decisions in multiple sclerosis — insights from real-world observational studies
- (2017) Maria Trojano et al. Nature Reviews Neurology
- Older Age at Multiple Sclerosis Onset Is an Independent Factor of Poor Prognosis: A Population-Based Cohort Study
- (2017) Francis Guillemin et al. NEUROEPIDEMIOLOGY
- Brain mapping in multiple sclerosis: Lessons learned about the human brain
- (2017) Massimo Filippi et al. NEUROIMAGE
- Alemtuzumab CARE-MS I 5-year follow-up
- (2017) Eva Havrdova et al. NEUROLOGY
- Fast multiple sclerosis progression in North Africans
- (2017) Youssef Sidhom et al. NEUROLOGY
- Alemtuzumab CARE-MS II 5-year follow-up
- (2017) Alasdair J. Coles et al. NEUROLOGY
- Autologous hematopoietic stem cell transplantation in multiple sclerosis
- (2017) Maria Pia Sormani et al. NEUROLOGY
- Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012
- (2017) Sarah Burkill et al. NEUROLOGY
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2017) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
- (2017) Xavier Montalban et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years
- (2017) Sergio E. Baranzini et al. TRENDS IN GENETICS
- Dominant Optic Atrophy and Leber’s Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches
- (2017) Bo Young Chun et al. Seminars in Pediatric Neurology
- Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
- (2017) Paolo A. Muraro et al. JAMA Neurology
- Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor
- (2017) Georgina Arrambide et al. Multiple Sclerosis Journal
- Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm
- (2017) Andrew J Solomon et al. Multiple Sclerosis Journal
- Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
- (2017) Maria Pia Amato et al. Multiple Sclerosis Journal
- Targets of therapy in progressive MS
- (2017) Hans Lassmann Multiple Sclerosis Journal
- New insights into the burden and costs of multiple sclerosis in Europe
- (2017) Gisela Kobelt et al. Multiple Sclerosis Journal
- Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
- (2017) Fredrik Piehl et al. Multiple Sclerosis Journal
- “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
- (2017) Gavin Giovannoni et al. Multiple Sclerosis Journal
- Vitamin D and multiple sclerosis: An update
- (2017) Charles Pierrot-Deseilligny et al. Multiple Sclerosis and Related Disorders
- Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions
- (2016) P. Brenner et al. ACTA NEUROLOGICA SCANDINAVICA
- MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis
- (2016) Letizia Leocani et al. CURRENT OPINION IN NEUROLOGY
- TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE
- (2016) C Alvarez-Gonzalez et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
- (2016) Fred Lublin et al. LANCET
- Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial
- (2016) Rhian Raftopoulos et al. LANCET NEUROLOGY
- MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
- (2016) Massimo Filippi et al. LANCET NEUROLOGY
- Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
- (2016) Jeffrey A Cohen et al. LANCET NEUROLOGY
- A Multidimensional Computerized Adaptive Short-Form Quality of Life Questionnaire Developed and Validated for Multiple Sclerosis
- (2016) Pierre Michel et al. MEDICINE
- Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
- (2016) Axel Petzold et al. Multiple Sclerosis Journal
- Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions
- (2016) Niraj Mistry et al. Multiple Sclerosis Journal
- Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome
- (2016) WJ Brownlee et al. Multiple Sclerosis Journal
- Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
- (2016) Ludwig Kappos et al. Multiple Sclerosis Journal
- Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
- (2016) Tomas Olsson et al. Nature Reviews Neurology
- The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
- (2016) Pascal Sati et al. Nature Reviews Neurology
- The APOSTEL recommendations for reporting quantitative optical coherence tomography studies
- (2016) Andrés Cruz-Herranz et al. NEUROLOGY
- Recommendations for observational studies of comorbidity in multiple sclerosis
- (2016) Ruth Ann Marrie et al. NEUROLOGY
- The challenge of comorbidity in clinical trials for multiple sclerosis
- (2016) Ruth Ann Marrie et al. NEUROLOGY
- The contemporary spectrum of multiple sclerosis misdiagnosis
- (2016) Andrew J. Solomon et al. NEUROLOGY
- Brain MRI atrophy quantification in MS
- (2016) Maria A. Rocca et al. NEUROLOGY
- Neurofilament light chain level is a weak risk factor for the development of MS
- (2016) Georgina Arrambide et al. NEUROLOGY
- Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis
- (2016) Tingting Zhang et al. NEUROLOGY
- Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention—An Update
- (2016) Kassandra Munger et al. SEMINARS IN NEUROLOGY
- Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells
- (2016) Francesca Ronchi et al. Nature Communications
- Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis
- (2016) Ludwig Kappos et al. JAMA Neurology
- Elevated CSF neurofilament proteins predict brain atrophy: A 15-year follow-up study
- (2016) Axel Petzold et al. Multiple Sclerosis Journal
- Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions
- (2016) Niraj Mistry et al. Multiple Sclerosis Journal
- Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome
- (2016) WJ Brownlee et al. Multiple Sclerosis Journal
- Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
- (2016) Ludwig Kappos et al. Multiple Sclerosis Journal
- Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis
- (2016) K.M. Fiest et al. Multiple Sclerosis and Related Disorders
- Brain health: time matters in multiple sclerosis
- (2016) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- The Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigue
- (2016) Christian Veauthier et al. EPMA Journal
- Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
- (2016) DE Moulin et al. Pain Research & Management
- Melanoma cell adhesion molecule-positive CD8 T lymphocytes mediate central nervous system inflammation
- (2015) Catherine Larochelle et al. ANNALS OF NEUROLOGY
- Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque
- (2015) Josa M. Frischer et al. ANNALS OF NEUROLOGY
- Dynamics of retinal injury after acute optic neuritis
- (2015) Iñigo Gabilondo et al. ANNALS OF NEUROLOGY
- Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis
- (2015) Tanja Jürgens et al. BRAIN
- Defining high, medium and low impact prognostic factors for developing multiple sclerosis
- (2015) Mar Tintore et al. BRAIN
- Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample
- (2015) Fraser Moore et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- Expression of GM-CSF in T Cells Is Increased in Multiple Sclerosis and Suppressed by IFN-β Therapy
- (2015) Javad Rasouli et al. JOURNAL OF IMMUNOLOGY
- Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis
- (2015) Tessa Dhaeze et al. JOURNAL OF IMMUNOLOGY
- ATON: Results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis
- (2015) Robert C. Sergott et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis
- (2015) Maria A Rocca et al. LANCET NEUROLOGY
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies—conflicting results?
- (2015) Bernhard Hemmer Multiple Sclerosis Journal
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy
- (2015) Alfredo Damasceno et al. Multiple Sclerosis Journal
- Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
- (2015) Immy A Ketelslegers et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
- (2015) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process
- (2015) Àlex Rovira et al. Nature Reviews Neurology
- Body fluid biomarkers for multiple sclerosis—the long road to clinical application
- (2015) Charlotte E. Teunissen et al. Nature Reviews Neurology
- Focal disturbances in the blood–brain barrier are associated with formation of neuroinflammatory lesions
- (2015) Jorge Ivan Alvarez et al. NEUROBIOLOGY OF DISEASE
- Long-term assessment of no evidence of disease activity in relapsing-remitting MS
- (2015) Nicola De Stefano et al. NEUROLOGY
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
- (2015) J. Kuhle et al. NEUROLOGY
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis
- (2015) Yonghao Cao et al. Science Translational Medicine
- Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study
- (2015) Lauren E. Mokry et al. PLOS MEDICINE
- Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
- (2015) Dalia L. Rotstein et al. JAMA Neurology
- Antibodies to the inward rectifying potassium channel 4.1 in multiple sclerosis: different methodologies—conflicting results?
- (2015) Bernhard Hemmer Multiple Sclerosis Journal
- Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study
- (2015) J Kuhle et al. Multiple Sclerosis Journal
- No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy
- (2015) Alfredo Damasceno et al. Multiple Sclerosis Journal
- Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort
- (2015) Immy A Ketelslegers et al. Multiple Sclerosis Journal
- Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
- (2015) M Alba Mañé Martínez et al. Multiple Sclerosis Journal
- The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
- (2015) Ruth Ann Marrie et al. Multiple Sclerosis Journal
- Remyelination Therapy in Multiple Sclerosis
- (2015) Danielle E. Harlow et al. Frontiers in Neurology
- Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial
- (2015) Johannes M. van Noort et al. PLoS One
- Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy
- (2014) Tatiana Plavina et al. ANNALS OF NEUROLOGY
- Role of the Blood–Brain Barrier in Multiple Sclerosis
- (2014) Genaro Gabriel Ortiz et al. ARCHIVES OF MEDICAL RESEARCH
- Vision and vision-related outcome measures in multiple sclerosis
- (2014) L. J. Balcer et al. BRAIN
- Relapsing and progressive forms of multiple sclerosis
- (2014) Ranjan Dutta et al. CURRENT OPINION IN NEUROLOGY
- Magnetic resonance outcome measures in multiple sclerosis trials
- (2014) Massimo Filippi et al. CURRENT OPINION IN NEUROLOGY
- Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
- (2014) Arumugam Palanichamy et al. JOURNAL OF IMMUNOLOGY
- A changing treatment landscape for multiple sclerosis: challenges and opportunities
- (2014) F. Piehl JOURNAL OF INTERNAL MEDICINE
- N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis
- (2014) Alessandro Trentini et al. JOURNAL OF NEUROLOGY
- Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
- (2014) Lukas Haider et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study
- (2014) Adipong Brickshawana et al. LANCET NEUROLOGY
- Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Christian Confavreux et al. LANCET NEUROLOGY
- Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria
- (2014) S Schippling et al. Multiple Sclerosis Journal
- Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis
- (2014) Divya Narayanan et al. Multiple Sclerosis Journal
- Effect of Alfacalcidol on multiple sclerosis-related fatigue: A randomized, double-blind placebo-controlled study
- (2014) Anat Achiron et al. Multiple Sclerosis Journal
- The investigation of acute optic neuritis: a review and proposed protocol
- (2014) Axel Petzold et al. Nature Reviews Neurology
- Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis
- (2014) A. K. Hedstrom et al. NEUROLOGY
- Epitope spreading as an early pathogenic event in pediatric multiple sclerosis
- (2014) F. J. Quintana et al. NEUROLOGY
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors
- (2014) Milena A. Gianfrancesco et al. Obesity Research & Clinical Practice
- Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event
- (2014) Darin T. Okuda et al. PLoS One
- Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
- (2014) A. Palanichamy et al. Science Translational Medicine
- B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes
- (2014) J. N. H. Stern et al. Science Translational Medicine
- Urodynamics in the Evaluation of the Patient with Multiple Sclerosis
- (2014) Benjamin E. Dillon et al. UROLOGIC CLINICS OF NORTH AMERICA
- Towards the implementation of ‘no evidence of disease activity’ in multiple sclerosis treatment: the multiple sclerosis decision model
- (2014) Martin Stangel et al. Therapeutic Advances in Neurological Disorders
- miR-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization
- (2013) Craig S. Moore et al. ANNALS OF NEUROLOGY
- Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis
- (2013) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis
- (2013) Sofia V. Abrahamsson et al. BRAIN
- Cortical imaging in multiple sclerosis
- (2013) Marita Daams et al. CURRENT OPINION IN NEUROLOGY
- A practical approach to diagnosing adult onset leukodystrophies
- (2013) R. M. Ahmed et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude
- (2013) R. Dobson et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials
- (2013) Maria Pia Sormani et al. LANCET NEUROLOGY
- Body fluid biomarkers in multiple sclerosis
- (2013) Manuel Comabella et al. LANCET NEUROLOGY
- Optic neuritis
- (2013) Ahmed T Toosy et al. LANCET NEUROLOGY
- Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes
- (2013) Vittorio Martinelli et al. Multiple Sclerosis Journal
- Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome
- (2013) Timm Oberwahrenbrock et al. Multiple Sclerosis Journal
- Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
- (2013) Ashley H Beecham et al. NATURE GENETICS
- Epstein-Barr virus in oral shedding of children with multiple sclerosis
- (2013) C. Yea et al. NEUROLOGY
- Gray matter damage predicts the accumulation of disability 13 years later in MS
- (2013) M. Filippi et al. NEUROLOGY
- Mortality in patients with multiple sclerosis
- (2013) A. Scalfari et al. NEUROLOGY
- Grey matter damage in multiple sclerosis
- (2013) Roel Klaver et al. Prion
- Sleep disorders in multiple sclerosis and their relationship to fatigue
- (2013) Christian Veauthier et al. SLEEP MEDICINE
- Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
- (2013) Daniela F. Angelini et al. PLoS Pathogens
- Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment
- (2013) Agata Walczak et al. JAMA Neurology
- Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis
- (2013) Shiv Saidha et al. JAMA Neurology
- Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis
- (2012) Sung R. Choi et al. BRAIN
- IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis
- (2012) Magdalena Huber et al. JOURNAL OF CLINICAL INVESTIGATION
- B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells
- (2012) Tom A. Barr et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
- (2012) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Patients with migraine do not have MRI-visible cortical lesions
- (2012) Martina Absinta et al. JOURNAL OF NEUROLOGY
- Treatment of cognitive impairment in multiple sclerosis: position paper
- (2012) Maria Pia Amato et al. JOURNAL OF NEUROLOGY
- B-Cell Enrichment and Epstein-Barr Virus Infection in Inflammatory Cortical Lesions in Secondary Progressive Multiple Sclerosis
- (2012) Roberta Magliozzi et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Clinically isolated syndromes
- (2012) David H Miller et al. LANCET NEUROLOGY
- High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women
- (2012) Anna K Hedström et al. Multiple Sclerosis Journal
- Effect of gender on late-onset multiple sclerosis
- (2012) Riley M Bove et al. Multiple Sclerosis Journal
- CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome
- (2012) M Khalil et al. Multiple Sclerosis Journal
- Progressive multiple sclerosis: pathology and pathogenesis
- (2012) Hans Lassmann et al. Nature Reviews Neurology
- Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis
- (2012) M. H. Sombekke et al. NEUROLOGY
- No MRI evidence of cortical lesions in neuromyelitis optica
- (2012) M. Calabrese et al. NEUROLOGY
- Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis
- (2012) T. Sinnecker et al. NEUROLOGY
- Postmortem verification of MS cortical lesion detection with 3D DIR
- (2012) A. Seewann et al. NEUROLOGY
- Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis
- (2012) Rajneesh Srivastava et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gestational vitamin D and the risk of multiple sclerosis in offspring
- (2011) Fariba Mirzaei et al. ANNALS OF NEUROLOGY
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis
- (2011) Ajit Singh Dhaunchak et al. ANNALS OF NEUROLOGY
- Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis
- (2011) Anna Karin Hedström et al. BRAIN
- CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
- (2011) Viviana Annibali et al. BRAIN
- Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
- (2011) Owain W. Howell et al. BRAIN
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- (2011) A. Novotna et al. EUROPEAN JOURNAL OF NEUROLOGY
- Cost of disorders of the brain in Europe 2010
- (2011) Anders Gustavsson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Epstein-Barr virus and multiple sclerosis: interaction with HLA
- (2011) E Sundqvist et al. GENES AND IMMUNITY
- Role of gender in multiple sclerosis: Clinical effects and potential molecular mechanisms
- (2011) Judith M. Greer et al. JOURNAL OF NEUROIMMUNOLOGY
- Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada
- (2011) E Kingwell et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The effect of gender in clinically isolated syndrome (CIS): a meta-analysis
- (2011) Ruth Dobson et al. Multiple Sclerosis Journal
- Multiple sclerosis and depression
- (2011) Anthony Feinstein Multiple Sclerosis Journal
- Cortical lesions in radiologically isolated syndrome
- (2011) A. Giorgio et al. NEUROLOGY
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence
- (2011) J. I. Alvarez et al. SCIENCE
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- A phase 3 trial of extended release oral dalfampridine in multiple sclerosis
- (2010) Andrew D. Goodman et al. ANNALS OF NEUROLOGY
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis
- (2010) Roberta Magliozzi et al. ANNALS OF NEUROLOGY
- Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients
- (2010) Ranjan Dutta et al. ANNALS OF NEUROLOGY
- Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
- (2010) Laura Piccio et al. ARCHIVES OF NEUROLOGY
- Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration
- (2010) A. J. Green et al. BRAIN
- The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability
- (2010) Antonio Scalfari et al. BRAIN
- Interpreting scores on multiple sclerosis-specific patient reported outcome measures (the PRIMUS and U-FIS)
- (2010) James Twiss et al. Health and Quality of Life Outcomes
- The changing demographic pattern of multiple sclerosis epidemiology
- (2010) Nils Koch-Henriksen et al. LANCET NEUROLOGY
- Emerging effects of comorbidities on multiple sclerosis
- (2010) Ruth Ann Marrie et al. LANCET NEUROLOGY
- Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis
- (2010) Axel Petzold et al. LANCET NEUROLOGY
- Neurofilament light as a prognostic marker in multiple sclerosis
- (2010) Jonatan Salzer et al. Multiple Sclerosis Journal
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- (2010) C. Collin et al. NEUROLOGICAL RESEARCH
- Brainstem lesions in clinically isolated syndromes
- (2010) M. Tintore et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferential recruitment of interferon-γ-expressing TH17 cells in multiple sclerosis
- (2009) Hania Kebir et al. ANNALS OF NEUROLOGY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis
- (2009) Jan D. Lünemann et al. ANNALS OF NEUROLOGY
- Smoking and Disease Progression in Multiple Sclerosis
- (2009) Brian C. Healy et al. ARCHIVES OF NEUROLOGY
- MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome
- (2009) Jessica M Nielsen et al. BMC Neurology
- CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
- (2009) J. M. Fletcher et al. JOURNAL OF IMMUNOLOGY
- Clinical predictors of early second event in patients with clinically isolated syndrome
- (2009) Ellen M. Mowry et al. JOURNAL OF NEUROLOGY
- Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study
- (2009) A Giordano et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter
- (2009) Marco Vercellino et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Responsiveness of patient-based and external rating scales in multiple sclerosis: Head-to-head comparison in three clinical settings
- (2009) Stefan M. Gold et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial
- (2009) Andrew D Goodman et al. LANCET
- Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study
- (2009) Eva Havrdova et al. LANCET NEUROLOGY
- Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
- (2009) Philip L De Jager et al. LANCET NEUROLOGY
- CADASIL
- (2009) Hugues Chabriat et al. LANCET NEUROLOGY
- The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)
- (2009) LC Doward et al. Multiple Sclerosis Journal
- Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes
- (2009) Valentina Zipoli et al. Multiple Sclerosis Journal
- Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci
- (2009) Philip L De Jager et al. NATURE GENETICS
- Clinical prognostic factors in multiple sclerosis: a natural history review
- (2009) Alexandra Degenhardt et al. Nature Reviews Neurology
- A reassessment of the plateauing relationship between T2 lesion load and disability in MS
- (2009) M. P. Sormani et al. NEUROLOGY
- Remyelination capacity of the MS brain decreases with disease chronicity
- (2009) T. Goldschmidt et al. NEUROLOGY
- Sleep disorders in patients with multiple sclerosis
- (2009) Steven D. Brass et al. SLEEP MEDICINE REVIEWS
- Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
- (2008) L. K. Fisniku et al. BRAIN
- Regulatory T cells fail to suppress CD4+ T-bet+T cells in relapsing multiple sclerosis patients
- (2008) Giovanni Frisullo et al. IMMUNOLOGY
- EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
- (2008) Jan D. Lünemann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-12– and IL-23–modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition
- (2008) Mark A. Kroenke et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord
- (2008) C P Gilmore et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography
- (2008) F Costello et al. Multiple Sclerosis Journal
- Smoking is a risk factor for early conversion to clinically definite multiple sclerosis
- (2008) F Di Pauli et al. Multiple Sclerosis Journal
- Remyelination in the CNS: from biology to therapy
- (2008) Robin J. M. Franklin et al. NATURE REVIEWS NEUROSCIENCE
- Variants of Multiple Sclerosis
- (2008) Jack H. Simon et al. NEUROIMAGING CLINICS OF NORTH AMERICA
- Temporal trends in the incidence of multiple sclerosis: A systematic review
- (2008) A. Alonso et al. NEUROLOGY
- The Immunology of Multiple Sclerosis
- (2008) Amit Bar-Or SEMINARS IN NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started